Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • How Omicron dodges the immune system

    The current wave of COVID-19 highlights a particularly high risk of reinfection by the Omicron variant of SARS-CoV-2. Why is this? A team from the Centre for Emerging Viral Diseases of the University of Geneva (UNIGE) and of the Geneva University Hospital (HUG) analysed the antibody neutralisation capacity of 120 people infected with the original SARS-CoV-2 strain, or with one of its Alpha, Beta, Gamma, Delta, Zeta or Omicron (sub-variant BA.1) variants.

  • Pharma companies to share data on antimicrobial resistance

    The initiative launched last month (21 June) by Vivli, a non-profit clinical research data sharing organisation, will enable scientists from all over the world to access data on epidemiological, physical and genetic characteristics of organisms and their resistance to various antibiotics.

  • Study could help better management of Alzheimer’s patients

    A team of researchers at the Bengaluru-based Indian Institute of Science (IISc) has developed a GPU-based machine learning algorithm that promises to help identify early signs of aging or deterioration of brain function before they manifest behaviourally in Alzheimers patients.

    admin Tue, 07/05/2022 - 15:50
  • Time to move from Volume to Value leadership to capture global market, Says Health Minister

    Let us move from Volume to Value leadership to capture global pharmaceutical market. It is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop our own models focused on accelerating production to meet the domestic demand while increasing our global footprint. Union Minister for Chemicals & Fertilizers and Health & Family Welfare, Dr. Mansukh Mandaviya exhorted the champions and leaders of Pharmaceutical Industry at the interactive session with Indian Pharmaceutical Alliance.

    admin Mon, 07/04/2022 - 16:10
  • 9th edition of Indian Pharmacopoeia is released by IPC

    Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Dr. Mansukh Mandaviya chaired IPC Conference 2022 and released 9th edition of Indian Pharmacopoeia on 1st July at Vigyan Bhawan, New Delhi.

    admin Mon, 07/04/2022 - 16:05
  • NIPER SAS Nagar student gets Rs. 27.8 lakh annual package

    NIPER SAS Nagar has informed that the highest annual package offered to a student is Rs. 27.8 lakh. Many companies conducted campus interviews for the M.Pharm or Masters students of the batch 2020-22.

    admin Fri, 07/01/2022 - 16:25
  • Dr Reddys Laboratories has settled patent litigation with Indivior Inc and Aquestive Therapeutics

    Dr Reddys Laboratories has settled patent litigation with Indivior Inc and Aquestive Therapeutics on a medication used to treat opioid dependence or addiction. A US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.

    admin Fri, 07/01/2022 - 16:19
  • Novartis starts new manufacturing plant in Mumbai

    Novartis starts a new plant in Mumbai to make generic cancer drugs. It said that to reinforce our commitment to improving and extending people’s lives, Sandoz Technical Operations, a Novartis division, inaugurated its manufacturing plant for medicines and therapies at Kalwe in Mumbai today.

    The plant, which marks a new chapter for Sandoz, will further strengthen the company’s operations in India to support growing healthcare needs globally.

    admin Fri, 07/01/2022 - 16:13
  • Higher Protein Intake While Dieting Leads to Healthier Eating

    Eating a larger proportion of protein while dieting leads to better food choices and helps avoid the loss of lean body mass, according to a Rutgers study.

    An analysis of pooled data from multiple weight-loss trials conducted at Rutgers shows that increasing the amount of protein even slightly, from 18 percent of a person’s food intake to 20 percent, has a substantial impact on the quality of the food choices made by the person. The study was published in the medical journal Obesity.

    admin Tue, 06/28/2022 - 15:42
  • Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease ; study finds

    A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to Mayo Clinic researchers.

    admin Tue, 06/28/2022 - 15:32
Subscribe to Pharma News

Search this website